Credit Suisse Securities (USA) LLC, J.P. Morgan Securities LLC Underwriters: Canaccord Genuity Inc, Stifel Nicolaus & Company Incorporated Summary of TRIV TRIV is a medical device company engaged in the development and commercialization
underwriters, including J.P. Morgan Securities LLC, Deutsche Bank Securities Inc, Morgan Stanley & Co LLC, Stifel Nicolaus & Company Inc, Jefferies LLC, and William Blair and Co LLC, will attempt to energize the stock with an infusion of
for RNA interference, some analysts remain bullish . RBC Capital has a $30 PT on the stock and Maxim Group has $31. Stifel Nicolaus is a bit more modest with $19. Most of the firm's 2013 revenue of $15.5M came from its contract with the DOD for
of the Osisko deal, I find additional encouragement for the broader commodities space, as well as for gold, from Stifel Nicolaus ’ Barry Banister. His strategy for the second quarter of the year is that we may see a one-year rally in commodity-related
Lebenthal & Co LLC, Loop Capital Markets LLC, Mischler Financial Group Inc, Raymond James and Associates Inc, RBC Capital Markets LLC, Samuel A. Ramirez & Company Inc, Stifel Nicolaus & Company Incorporated, Wells Complete Story »
Stifel Nicolaus upgrades Nike ( NKE ) to a Buy rating after finding valuation attractive with shares down almost 12% from their March highs. The investment firm sets a $87 price target on the stock. NKE +0.7% premarket Post your comment!
Securities Inc, Leerink Partners LLC, Mizuho Securities USA Inc, Piper Jaffray & Co, RBC Capital Markets LLC, Stifel Nicolaus & Company Incorporated, Suntrust Robinson Humphrey Inc, TPG Capital BD LLC, Wells Fargo Securities LLC, William Blair
Stifel Nicolaus cuts its rating on Beam ( BEAM ) to Hold from Buy on a valuation call. Shares of BEAM are up 22.4% YTD. Post your comment!
Underwriters: Citigroup Global Markets Inc, Credit Suisse Securities LLC, JP Morgan Securities LLC Underwriters: Stifel Nicolaus & Company Inc, Suntrust Robinson Humphrey Inc Summary EVDY uses data and analytics technology to provide its users with
President and CEO Chuck Cashion - Senior Vice President and CFO Analysts Roy Buchanan - Piper Jaffray Stephen Willey - Stifel Nicolaus John Boris - SunTrust Bert Hazlett - ROTH Capital Presentation Operator Welcome to the Conatus Pharmaceuticals fourth quarter